Viewing Study NCT00092157



Ignite Creation Date: 2024-05-05 @ 11:37 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00092157
Status: COMPLETED
Last Update Posted: 2022-02-15
First Post: 2004-09-21

Brief Title: Effectiveness of Two Approved Drugs in Lowering High Cholesterol 0733-224
Sponsor: Organon and Co
Organization: Organon and Co

Study Overview

Official Title: A Multicenter Randomized Double-Blind Parallel Group Study to Evaluate the Tolerability and Efficacy of the Co-Administration of Simvastatin 20 mgDay and Fenofibrate 160 mgDay Compared to Simvastatin 20 mgDay Alone for 12 Weeks of Treatment in Patients With Combined Hyperlipidemia-Simvastatin and Fenofibrate Efficacy Trial SAFARI
Status: COMPLETED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together compared to taking only one of the drugs
Detailed Description: The duration of treatment is 12 weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2004_060 None None None